Hormones lower Alzheimer’s incidences. A study in Psychoneuroendodrinology (2005) and reviewed again in 2015, showed women ages 65 to 84 that had the greatest total estrogen exposure showed the least cognitive impairment. The women using Bioidentical Hormone Replacement, estradiol, had an average of 40% reduction in the risk of cognitive impairment.

Bio identical estrogens, as well as progesterone and testosterone in lab animal studies, provided importantneuroprotection in the brain.

To summarize, “Based on extensive laboratory evidence, it seems likely that menopausal hormone replacement may enhance cognitive function and reduce the risks of Dementia and Alzheimer’s disease.”- Dr. Johnathan V. Wright, M.D, published author and pioneer in hormone replacement.